about
Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiologyImmune response to mycobacterial infection: lessons from flow cytometryIncreased levels of osteopontin in sputum supernatant of smoking asthmaticsSubjects hospitalized with the 2009 pandemic influenza A (H1N1) virus in a respiratory infection unit: clinical factors correlating with ICU admission.Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients.Driving-Related Neuropsychological Performance in Stable COPD Patients.Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen.Dyspnea and respiratory muscle strength in end-stage liver disease.Survival and Quality of Life Benefit after Endoscopic Management of Malignant Central Airway Obstruction.Inflammation and immune response in COPD: where do we stand?Effect of rehabilitative exercise training on peripheral muscle remodelling in patients with COPD: targeting beyond the lungs.Critically ill cancer patient in intensive care unit: issues that arise.Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD).Predictors of future exacerbation risk in patients with asthma.Prolonged occupational exposure leads to allergic airway sensitization and chronic airway and systemic inflammation in professional firefighters.Fever and multilobular mass of the right lung in a young adult with asthma.A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014.Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma.Meloxicam-induced pulmonary infiltrates with eosinophilia: a case report.Unevenness of ventilation assessed by the expired CO(2) gas volume versus V(T) curve in asthmatic patients.Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea.Very limited usefulness of pulse pressure variation as a predictor of volume responsiveness in critically ill septic patients.Activity monitoring reflects cardiovascular and metabolic variations in COPD patients across GOLD stages II to IV.Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura.Effects of exercise-induced arterial hypoxaemia and work rate on diaphragmatic fatigue in highly trained endurance athletes.Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD.Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma.Expiratory flow limitation in morbidly obese postoperative mechanically ventilated patients.Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.Heart rate recovery post 6-minute walking test in obstructive sleep apnea: cycle ergometry versus 6-minute walking test in OSA patients.High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trial.Cardiovascular effects of high-intensity interval aerobic training combined with strength exercise in patients with chronic heart failure. A randomized phase III clinical trial.Respiratory mechanics in brain-damaged patients.Why high levels of positive end-expiratory pressure are required to maintain a stable end-expiratory lung volume in morbidly obese subjects.Activin A and follistatin in patients with asthma. Does severity make the difference?Interval training induces clinically meaningful effects in daily activity levels in COPD.Sputum interleukin-13 as a biomarker for the evaluation of asthma control.Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.Hemodynamic effects of high intensity interval training in COPD patients exhibiting exercise-induced dynamic hyperinflation.Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma.
P50
Q22299204-EC87822B-AC93-46FD-9C9F-8847184A8466Q27002561-7A300CFB-9B7A-4B54-AA6B-E413A9BFFA44Q28277953-BD6D0022-C943-4425-92A7-E0636E0E3BF6Q30365656-2E19E68F-FA85-42A4-AE3F-2EFCABE0BDD7Q30437289-DE447242-CC7B-460D-AB19-24FDD6916C85Q30458104-DCD2E45E-3B5C-444A-ABC5-69EFD990F761Q34442119-7A1C63D3-2AC9-4FC3-993C-0E138ED9BC3FQ36812846-A8E9DBEC-A877-4624-A02E-76821A21B422Q36882556-CE6120AD-51B1-4074-85FC-1E333DFBB831Q37057836-E5AFABD7-4872-4297-9609-64B3214B33B0Q38068949-D84E02DD-5E08-48FB-9730-CD2679AD4594Q38214384-3129F365-1191-4453-8CA7-BA1DBA1C5AE7Q38448151-A080BF8F-1C19-4A75-98F2-80754A206FEBQ38834113-7C4D904A-4751-454F-9977-57BB2B4F00E9Q39437600-FD2E9E4B-C284-41D3-A870-0BDEB9B98B21Q40119045-37236727-04C5-483F-A6BD-03E3AAC749B4Q40208587-92E54F7F-3908-4BE8-B400-C2BB1F4691BEQ41357634-1B1E9352-1B4B-4F88-AB54-EDD1313EC35FQ44552223-84C37C75-0FB3-4A7D-A9FE-AA8F681C8F2BQ44928710-CD84D3C7-D67B-49DD-A62E-3260C7F3710DQ45139681-5E652875-F5E1-4BE7-AE6B-8EDA6C24C5CCQ45962063-6F267BFA-86CF-45D6-B5E3-670B419B258CQ46053755-6C56D0F5-DE8B-4319-9FD3-30F249872CE8Q46433272-833F358F-32B1-4A86-B27E-51CAA906985EQ46913552-D2A399F7-9579-44EA-A333-77467440ECAAQ47613067-F37EB680-6F2E-4B67-8ED8-670A127FAA73Q47929252-7E99E7A7-703F-4BA8-BBDA-6FC3B00DAE59Q47930725-C877394B-702C-4781-9105-BC3F756B6858Q48024317-5CAD5FED-3C56-4BEE-B348-B82EF8F68F50Q48107296-16E293B3-8B2D-44B3-9486-667B0065A564Q48159683-BBAE4D96-4A0D-40CF-9309-4F3DC3BC9D70Q48160509-66A151A0-A902-4DFE-AE97-05E798B9678AQ48391647-44A7EC1B-1068-4594-B4C4-846B774D5FC6Q48599265-BC4EFD80-E72F-4FF5-8EC8-F261D9A4C060Q51347768-3550868C-461E-4F40-B310-2A526D56177EQ51502577-25913BE8-35CF-4CB4-989E-6C75672EACD0Q51539024-88ADB19F-C4AA-49CB-8AC5-67CD97BEE115Q51590724-202B96D2-0E4C-4BA5-B65E-0243FF4E5DD3Q51618110-4DEC3298-02F4-4B35-94C3-10FA9C1AB20FQ51654211-96E42A3B-87E8-4F59-A4E8-7C0DAA197704
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nikolaos Koulouris
@ast
Nikolaos Koulouris
@en
Nikolaos Koulouris
@es
Nikolaos Koulouris
@nl
type
label
Nikolaos Koulouris
@ast
Nikolaos Koulouris
@en
Nikolaos Koulouris
@es
Nikolaos Koulouris
@nl
prefLabel
Nikolaos Koulouris
@ast
Nikolaos Koulouris
@en
Nikolaos Koulouris
@es
Nikolaos Koulouris
@nl
P106
P1153
6701716665
P31
P496
0000-0002-1719-7220